Concepedia

Robert T. Weigand

RT

2

Publications

652

Citations

2

H-Index

2006

Active since

Affiliations

International Drug Development Institute (Belgium)(Current)

Robert T. Weigand is an author at International Drug Development Institute (Belgium) specializing in breast cancer, radiation oncology, and medicine.

Top concepts

MedicineBreast CancerRadiation OncologyHealthOncologyPathologyBreast SurgeryCancer TherapyClinical TrialsPharmacotherapy

Publications per year

2006–2017

2

Publications

2

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

Miguel Martín, Frankie A. Holmes, Bent Ejlertsen et al. · The Lancet Oncology · 2017 · 578 citations

5-Year Analysis, Breast Oncology, Oncology +10

Pure primary squamous cell carcinoma of the breast: A rare presentation and clinicopathologic comparison with usual ductal carcinoma of the breast

Chakshu Gupta, Ashok K. Malani, Robert T. Weigand et al. · Pathology - Research and Practice · 2006 · 74 citations

Breast Oncology, Usual Ductal Carcinoma, Pathology +6

Rows per page

1–2 of 2